PreveCeutical Medical Inc.PreveCeutical Medical Inc.PreveCeutical Medical Inc.

PreveCeutical Medical Inc.

No trades
See on Supercharts
Market capitalization
‪9.43 M‬USD
−0.0018USD
‪−961.59 K‬USD
0.00USD
‪439.26 M‬
Beta (1Y)
0.66

About PREVECEUTICAL MEDICAL INC.


CEO
Stephen van Deventer
Headquarters
Vancouver
Founded
2014
FIGI
BBG00HFRKD23
PreveCeutical Medical, Inc. engages in licensing, branding, and marketing of nutraceutical and wellness products. The company was founded by Stephen Van Deventer, Kimberly Van Deventer, Greg Reid, Shabira Rajan, Mak Jawadekar, Harry Parekh, Nicole Goncalves-Krysinski, Lish Rebman, and Sydney Cole on December 15, 2014 and is headquartered in Vancouver, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PRVCF is 0.0159 USD — it has decreased by −15.87% in the past 24 hours. Watch PreveCeutical Medical Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange PreveCeutical Medical Inc. stocks are traded under the ticker PRVCF.
PRVCF stock has risen by 50.00% compared to the previous week, the month change is a 43.24% rise, over the last year PreveCeutical Medical Inc. has showed a −22.44% decrease.
PRVCF reached its all-time high on Feb 26, 2019 with the price of 0.2000 USD, and its all-time low was 0.0005 USD and was reached on Nov 1, 2019. View more price dynamics on PRVCF chart.
See other stocks reaching their highest and lowest prices.
PRVCF stock is 18.87% volatile and has beta coefficient of 0.66. Track PreveCeutical Medical Inc. stock price on the chart and check out the list of the most volatile stocks — is PreveCeutical Medical Inc. there?
Today PreveCeutical Medical Inc. has the market capitalization of ‪9.39 M‬, it has increased by 25.80% over the last week.
Yes, you can track PreveCeutical Medical Inc. financials in yearly and quarterly reports right on TradingView.
PRVCF net income for the last quarter is ‪−248.13 K‬ USD, while the quarter before that showed ‪−264.48 K‬ USD of net income which accounts for 6.18% change. Track more PreveCeutical Medical Inc. financial stats to get the full picture.
No, PRVCF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PRVCF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PreveCeutical Medical Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PreveCeutical Medical Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PreveCeutical Medical Inc. stock shows the sell signal. See more of PreveCeutical Medical Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.